ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2025

Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia.

Benoit Demuynck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.